Education
About Us
Working with TipRanks
Follow Us
Conduit Pharmaceuticals Inc. (CDT)
:CDT
CDT Stock Chart & Stats
Day’s Range― - ―
52-Week Range$1.09 - $392.00
Previous Close$0.08
Volume254.55M
Average Volume (3M)6.11M
Market Cap
$5.65M
Enterprise ValueN/A
Total Cash (Recent Filing)$370.30M
Total Debt (Recent Filing)$1.23B
Price to Earnings (P/E)―
Beta0.11
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-21.07
Shares Outstanding4,707,229
10 Day Avg. Volume1,076,926
30 Day Avg. Volume6,111,421
Standard Deviation0.40
R-Squared0.07
Alpha-0.10
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-0.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Conduit Pharmaceuticals News
PremiumMarket News
3 Penny Stocks to Watch Now, 2/11/25
PremiumCompany Announcements
Conduit Pharmaceuticals Awaits Nasdaq Decision on Compliance---
Ownership Overview
8.36% Insiders
0.68% Mutual Funds
0.07% Other Institutional Investors
90.40% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
CDT FAQ
What was Conduit Pharmaceuticals Inc.’s price range in the past 12 months?
Conduit Pharmaceuticals Inc. lowest stock price was $1.09 and its highest was $392.00 in the past 12 months.
What is Conduit Pharmaceuticals Inc.’s market cap?
Conduit Pharmaceuticals Inc.’s market cap is $5.65M.
When is Conduit Pharmaceuticals Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Conduit Pharmaceuticals Inc.’s earnings last quarter?
Currently, no data Available
Is Conduit Pharmaceuticals Inc. overvalued?
According to Wall Street analysts Conduit Pharmaceuticals Inc.’s price is currently Overvalued.
Does Conduit Pharmaceuticals Inc. pay dividends?
Conduit Pharmaceuticals Inc. does not currently pay dividends.
What is Conduit Pharmaceuticals Inc.’s EPS estimate?
Conduit Pharmaceuticals Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Conduit Pharmaceuticals Inc. have?
Conduit Pharmaceuticals Inc. has 4,707,229 shares outstanding.
What happened to Conduit Pharmaceuticals Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Conduit Pharmaceuticals Inc.?
Currently, no hedge funds are holding shares in CDT
---
Conduit Pharmaceuticals Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Hedge Fund Trend
Increased
By 18.0 Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 2.0%
Last 30 Days ▲ 22.4%
Last 30 Days ▲ 22.4%
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-99.57%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-75.10%
Trailing 12-Months
Company Description
Conduit Pharmaceuticals Inc.
Murphy Canyon Acquisition Corp is a blank check company.
---
Technical Analysis
---